MAPT and Cognitive impairment: As a link between Tau and Aβ deposition and cognitive decline in PD (Athauda and Foltynie, 2015), it is also worthwhile to evaluate the potential efficiency of LM-021 and LM-036 in treatment of cognitive impairments in PD.